<DOC>
	<DOCNO>NCT01843894</DOCNO>
	<brief_summary>Objectives : Primary - To determine safety tolerability escalate dos RU-101 4 week patient severe dry eye Secondary - To explore efficacy RU-101 - To explore optimal endpoint future study</brief_summary>
	<brief_title>A Phase 1/2 , RU-101 Ophthalmic Solution Patients With Severe Dry Eye</brief_title>
	<detailed_description>This Phase 1/2 , first-in-human , multicenter , dose escalation , double-masked , placebo control study consist two stage . In Stage I , 3 cohort plan evaluate escalating dos RU 101 ophthalmic solution , instill 6 time daily eye 4 week ( 28 day ) . Each cohort comprise 4 patient randomize 3:1 RU-101 placebo . A masked safety data review perform prior dose escalation determine dose limit toxicity ( DLTs ) occur define MTD high dose use Stage II . In Stage II , expand cohort receive dose define Stage I ( MTD high dose MTD reach ) , instill 6 time daily eye 12 week ( 84 day ) . The expanded cohort comprise approximately 96 patient randomize 1:1 RU-101 placebo , provide double-masked manner .</detailed_description>
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>1 . Male female patient age 18 80 year . 2 . Patients dry eye symptom least 4 month . 3 . Patients follow sign bad eye : 1 . Corneal stain score fluorescein stain ≥ 6/15 least one central 2 . Conjunctival stain score Lissamine Green ≥ 2/18 4 . Patients receive treatment eye drop artificial tear , Restasis , topical steroid insufficient efficacy find product intolerable . If use Restasis topical steroid , patient must agree 30day washout period prior first IP dose ( Day 0 ) . 5 . Female patient child bear potential must agree urine pregnancy test perform Screening ( must negative ) agree use medically acceptable form birth control ( e.g. , intrauterine device , birth control pill , patch subcutaneous implant , condom , diaphragm , abstinence ) throughout duration IP instillation . Women consider capable become pregnant include female experience menarche experience menopause ( define amenorrhea &gt; 12 consecutive month ) undergo successful surgical sterilization ( hysterectomy , bilateral tubal ligation , bilateral oophorectomy ) . 1 . Presence anterior eye disease except dry eye . 2 . Intraocular pressure ≥ 22 mmHg Screening . 3 . Use ophthalmic solution ( include overthecounter [ OTC ] solution ) , serum eye drop , contact lenses Treatment Phase . Artificial tear allow Screening Phase must use first dose ( Day 0 ) Treatment Phase . 4 . Use eye drop Restasis topical steroid within 30 day first dose ( Day 0 ) . 5 . Use antihistamine , beta blocker , tricyclic antidepressant , antidepressant anticholinergic side effect Treatment Phase . 6 . Patients previous corneal transplantation laserassisted situ keratomileusis ( LASIK ) . 7 . Presence graftversushost disease ( GVHD ) . 8 . Patients ocular surgery within 3 month prior first dose . 9 . Patients punctal plugs punctal cautery &lt; 3 month prior first dose . 10 . Patients severe dry eye due StevensJohnson disease ocular cicatricial pemphigoid . 11 . History allergy human serum protein product and/or history allergy yeast . 12 . History allergy recombinant product , ophthalmic solution , constituent RU 101 , solution plan use study . 13 . Any significant chronic illness , opinion Principal Investigator ( PI ) , could interfere study parameter . 14 . Use investigational product device within 30 day prior Screening Visit study . 15 . Known history alcohol and/or drug abuse within past 12 month , opinion PI could interfere study compliance , outcome measure include safety parameter , and/or general medical condition patient . 16 . Those unable opinion PI comply fully study requirement .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>sever dry eye , keratoconjunctivitis sicca</keyword>
</DOC>